Abstract
Five novel metalloproteinase protein inhibitors (MPIs) with molecular mass between 5.6 and 8.9 kDa and acid/neutral pI were detected in lupin seeds and exhibited strong inhibitory activities against thermolysin and/or gelatinase B. These novel peptides constitute not only the first MPIs described in plants but also the first plant peptides with inhibitory activity against a matrixin.
Keywords: Gelatinase B, lupin quiescent seed, matrixin peptide inhibitor, metalloproteinase protein inhibitor (MPI), thermolysin
Protein & Peptide Letters
Title: Discovery of Novel Plant Peptides as Strong Inhibitors of Metalloproteinases
Volume: 16 Issue: 5
Author(s): Dina M. Carrilho, Isabel C. Duarte, Rita Francisco, Candido P.P. Ricardo and Maria C. Duque-Magalhaes
Affiliation:
Keywords: Gelatinase B, lupin quiescent seed, matrixin peptide inhibitor, metalloproteinase protein inhibitor (MPI), thermolysin
Abstract: Five novel metalloproteinase protein inhibitors (MPIs) with molecular mass between 5.6 and 8.9 kDa and acid/neutral pI were detected in lupin seeds and exhibited strong inhibitory activities against thermolysin and/or gelatinase B. These novel peptides constitute not only the first MPIs described in plants but also the first plant peptides with inhibitory activity against a matrixin.
Export Options
About this article
Cite this article as:
Carrilho M. Dina, Duarte C. Isabel, Francisco Rita, Ricardo P.P. Candido and Duque-Magalhaes C. Maria, Discovery of Novel Plant Peptides as Strong Inhibitors of Metalloproteinases, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167789
DOI https://dx.doi.org/10.2174/092986609788167789 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Crosstalk Signalling Role in Modulation of Drugs Side Effects
Current Molecular Pharmacology Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin
Current Pharmaceutical Design Mesenchymal Stem Cells: Key Actors in Tumor Niche
Current Stem Cell Research & Therapy Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Betulinic Acid as a Potent and Complex Antitumor Phytochemical: A Minireview
Anti-Cancer Agents in Medicinal Chemistry Myxofibrosarcoma: Clinical and Prognostic Value of MRI Features
Current Medical Imaging HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Current Pharmaceutical Design Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy
Current Gene Therapy Cashew Gum A Versatile Hydrophyllic Polymer: A Review
Current Drug Therapy Development of Calixarenes, Cyclodextrins and Fullerenes as New Platforms for Anti-HIV Drug Design: An Overview
Mini-Reviews in Medicinal Chemistry Current Drug Targets for Thymic Neoplasms
Current Cancer Drug Targets Discovery of 4-Aryl-4H-Chromenes as Potent Apoptosis Inducers Using a Cell- and Caspase-Based Anti-Cancer Screening Apoptosis Program (ASAP): SAR Studies and the Identification of Novel Vascular Disrupting Agents
Anti-Cancer Agents in Medicinal Chemistry Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Current Pharmaceutical Design Antitumor and Antiviral Activity of Pentacyclic Triterpenes
Mini-Reviews in Organic Chemistry Nanocarriers for Tracking and Treating Diseases
Current Medicinal Chemistry Prevalence of HIV in Patients with Malignancy and of Malignancy in HIV Patients in a Tertiary Care Center from North India
Current HIV Research Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics Current Management of Neonatal Liver Tumors
Current Pediatric Reviews